Bliss GVS Pharma (BOM:506197) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 1991. Start your Free Trial

What is Bliss GVS Pharma Change In Receivables?

Bliss GVS Pharma's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Bliss GVS Pharma's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Bliss GVS Pharma's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-453 Mil. It means Bliss GVS Pharma's Accounts Receivable increased by ₹453 Mil from Mar. 2024 to Mar. 2025 .

Bliss GVS Pharma's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹4,384 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bliss GVS Pharma's Days Sales Outstanding for the three months ended in Mar. 2025 was 202.03.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bliss GVS Pharma's liquidation value for the three months ended in Mar. 2025 was ₹4,049 Mil.

Bliss GVS Pharma Change In Receivables Historical Data

The historical data trend for Bliss GVS Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bliss GVS Pharma Change In Receivables Chart

Bliss GVS Pharma Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

Get a 7-Day Free Trial

3.49

1,212.95

-663.37

-466.47

-453.08

Bliss GVS Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Bliss GVS Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Bliss GVS Pharma (BOM:506197) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bliss GVS Pharma's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	4383.562	/	1979.858	*	91
=	202.03

2. In Ben Graham's calculation of liquidation value, Bliss GVS Pharma's accounts receivable are only considered to be worth 75% of book value:

Bliss GVS Pharma's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2222.119	-	2089.924	+	0.75 * 4383.562	+	0.5 * 1257.296
=	4,049

Bliss GVS Pharma Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bliss GVS Pharma's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bliss GVS Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bliss GVS Pharma Ltd (BOM:506197) » Definitions » Change In Receivables

Traded in Other Exchanges

BLISSGVS:India

Address

Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072

Website

https://www.blissgvs.com

Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from exports.

Bliss GVS Pharma Headlines

No Headlines